Galmed Pharma (GLMD) Tops Q3 EPS by 19c

Galmed Pharma (NASDAQ: GLMD) reported Q3 EPS of $0.05, $0.19 better than the analyst estimate of ($0.14).

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.

You May Also Be Interested In

• Atkore Inc (ATKR) Tops Q3 EPS by 14c
• Bogota Financial Corp. (BSBK) Reports Q2 EPS of $0.06
• Barclays Upgrades Texas Capital Bancshares (TCBI) to Equalweight